Otolaryngological progression of granulomatosis with polyangiitis after systemic treatment with rituximab

Otolaryngology - Head and Neck Surgery (United States)

Volumn 150, Issue 1, 2014, Pages 68-72

  Kim, Young J ^a   Malm, Ian James ^a   Mener, David J ^a   Kim, Jean ^a   Seo, Philip ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

granulomatosis with polyangiitis; rituximab; Wegener's granulomatosis

Indexed keywords

CYCLOPHOSPHAMIDE; ETANERCEPT; GLUCOCORTICOID; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE SODIUM SUCCINATE; PREDNISONE; RITUXIMAB;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DEBRIDEMENT; DISEASE ACTIVITY SCORE; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG INFUSION; DRUG USE; ENDOSCOPY; FEMALE; FOLLOW UP; HEARING IMPAIRMENT; HUMAN; HUMORAL IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; LARYNGOSCOPY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; NOSE MALFORMATION; NOSE SEPTUM PERFORATION; OTORHINOLARYNGOLOGY; REMISSION; SINUSITIS; SUBGLOTTIC STENOSIS; SYSTEMIC THERAPY; TERTIARY HEALTH CARE; TREATMENT DURATION; WEGENER GRANULOMATOSIS; YOUNG ADULT;

EID: 84890831059     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599813509784     Document Type: Article

References (18)

1. Falk RJ, Gross WL, Guillevin L, et al. Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis. Arthritis Rheum. 2011 ; 63: 863-864
2. Seo P, Stone JH. The antineutrophil cytoplasmic antibody-associated vasculitides. Am J Med. 2004 ; 117: 39-50 (Pubitemid 38798019)
3. Cotch MF, Hoffman GS, Yerg DE, Kaufman GI, Targonski P, Kaslow RA. The epidemiology of Wegener's granulomatosis: estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources. Arthritis Rheum. 1996 ; 39: 87-92 (Pubitemid 26036382)
4. Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med. 1992 ; 116: 488-498
5. Martinez Del Pero M, Rasmussen N, Chaudhry A, Jani P, Jayne D. Structured clinical assessment of the ear, nose and throat in patients with granulomatosis with polyangiitis (Wegener's). Eur Arch Otorhinolaryngol. 2013 ; 270: 345-354
6. Srouji IA, Andrews P, Edwards C, Lund VJ. Patterns of presentation and diagnosis of patients with Wegener's granulomatosis: ENT aspects. J Laryngol Otol. 2007 ; 121: 653-658 (Pubitemid 47014205)
7. Stone JH, Merkel PA, Spiera R, et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010 ; 363: 221-232
8. Specks U, Merkel PA, Seo P, et al. Efficacy of remission-induction regimens for ANCA-associated vasculitis. N Engl J Med. 2013 ; 369: 417-427
9. Merkel PA, Seo P, Aries P, et al. Current status of outcome measures in vasculitis: focus on Wegener's granulomatosis and microscopic polyangiitis. Report from OMERACT 7. J Rheumatol. 2005 ; 32: 2488-2495 (Pubitemid 41780676)
10. Martinez Del Pero M, Chaudhry A, Jones RB, Sivasothy P, Jani P, Jayne D. B-cell depletion with rituximab for refractory head and neck Wegener's granulomatosis: a cohort study. Clin Otolaryngol. 2009 ; 34: 328-335
11. Holle JU, Dubrau C, Herlyn K, et al. Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations. Ann Rheum Dis. 2012 ; 71: 327-333
12. Roubaud-Baudron C, Pagnoux C, Méaux-Ruault N, et al. Rituximab maintenance therapy for granulomatosis with polyangiitis and microscopic polyangiitis. J Rheumatol. 2012 ; 39: 125-130
13. Geetha D, Seo P. Advances in therapy for ANCA-associated vasculitis. Curr Rheumatol Rep. 2012 ; 14: 509-515
14. Seo P, Specks U, Keogh KA. Efficacy of rituximab in limited Wegener's granulomatosis with refractory granulomatous manifestations. J Rheumatol. 2008 ; 35: 2017-2023
15. Aries PM, Hellmich B, Voswinkel J, et al. Lack of efficacy of rituximab in Wegener's granulomatosis with refractory granulomatous manifestations. Ann Rheum Dis. 2006 ; 65: 853-858
16. Aouba A, Pagnoux C, Bienvenu B, Mahr A, Guillevin L. Analysis of Wegener's granulomatosis responses to rituximab: current evidence and therapeutic prospects. Clin Rev Allergy Immunol. 2008 ; 34: 65-73
17. Taylor SC, Clayburgh DR, Rosenbaum JT, Schindler JS. Progression and management of Wegener's granulomatosis in the head and neck. Laryngoscope. 2012 ; 122: 1695-1700
18. Hellmich B, Flossmann O, Gross WL, et al. EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis. 2007 ; 66: 605-617 (Pubitemid 46707128)